UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis: A Randomized Controlled Trial

Annals of internal medicine, 2020-01, Vol.172 (2), p.86

2020

Volltextzugriff (PDF)

A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells

Cancer research (Chicago, Ill.), 2005-02, Vol.65 (3), p.732-742

2005

Volltextzugriff (PDF)

S283: THE NON‐ANTICOAGULANT HEPARINOID COMPOUND, SEVUPARIN, STRONGLY REDUCES HEPCIDIN EXPRESSION IN CELLS, IN MICE AND IN HEALTHY VOLUNTEERS

HemaSphere, 2023-08, Vol.7 (S3), p.e23664fa-n/a

2023

Volltextzugriff (PDF)

The Inflammatory Mediator Leukotriene D4 Induces β-Catenin Signaling and Its Association with Antiapoptotic Bcl-2 in Intestinal Epithelial Cells

The Journal of biological chemistry, 2006-03, Vol.281 (10), p.6776-6784

2006

Volltextzugriff (PDF)

A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer

European journal of cancer (1990), 2007, Vol.43 (7), p.1153-1160

2007

Volltextzugriff (PDF)

Regulation of leukotriene-dependent induction of cyclooxygenase-2 and Bcl-2

Biochemical and biophysical research communications, 2003-03, Vol.302 (2), p.330-335

2003

Volltextzugriff (PDF)

The Heparinoid Sevuparin Improves Anemia and Kidney Status in a Mouse Model of Chronic Kidney Disease

Blood, 2023-11, Vol.142 (Supplement 1), p.2463-2463

2023

Volltextzugriff (PDF)

The leukotriene receptor CysLT1 and 5-lipoxygenase are upregulated in colon cancer

Advances in experimental medicine and biology, 2003, Vol.525, p.201

2003

Volltextzugriff (PDF)

Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study

BMC medicine, 2006-06, Vol.4 (1), p.16-16, Article 16

2006

Volltextzugriff (PDF)

A phase 1/2 study with birinapant in combination with pembrolizumab

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS3131-TPS3131

2018

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled crossover study of α4β2 nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder

Psychopharmacology, 2014-03, Vol.231 (6), p.1251-1265

2014

Volltextzugriff (PDF)

Population pharmacokinetics and safety of AZD1446, a neuronal nicotinic receptor agonist, administered in healthy volunteers

Clinical pharmacology in drug development, 2014-01, Vol.3 (1), p.63-71

2014

Volltextzugriff (PDF)

Massive Fundic Gland Polyposis in a Patient Receiving Protracted Proton-Pump Inhibitor Medication

Anticancer research, 2010-01, Vol.30 (1), p.261-264

2010

Volltextzugriff (PDF)

Abstract 5101: Defining exposure-PD and efficacy relationships with the novel liver-targeting nucleotide prodrug MIV-818 for the treatment of liver cancers

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5101-5101

2017

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled crossover study of [alpha]^sub 4^[beta]^sub 2^ nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder

Psychopharmacology, 2014-03, Vol.231 (6), p.1251

2014

Volltextzugriff (PDF)

Do leukotrienes increase cell viability in human intestinal epithelial cells?

Advances in experimental medicine and biology, 2002, Vol.507, p.193

2002

Volltextzugriff (PDF)

Human papillomavirus, viral load and proliferation rate in recurrent respiratory papillomatosis in response to alpha interferon treatment

Journal of general virology, 2005-06, Vol.86 (6), p.1695-1702

2005

Volltextzugriff (PDF)

Pro-inflammatory mediator leukotriene D4 induces transcriptional activity of potentially oncogenic genes

Biochemical Society transactions, 2005-08, Vol.33 (Pt 4), p.698-700

2005

Volltextzugriff (PDF)

Inflammatory Mediator Leukotriene D₄ Induces [beta]-Catenin Signaling and Its Association with Antiapoptotic Bcl-2 in Intestinal Epithelial Cells

The Journal of biological chemistry, 2006, Vol.281 (10), p.6776-6784

2006

Volltextzugriff (PDF)

The inflammatory mediator leukotriene D4 induces beta -catenin signaling and its association with anti-apoptotic Bcl-2 in intestinal epithelial cells

The Journal of biological chemistry, 2006, Vol.281 (10), p.6776

2006

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled crossover study of α4β 2 nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder

Psychopharmacology (Berlin, Germany), 2014-03, Vol.231 (6), p.1251

2014

Volltextzugriff (PDF)

Efficacy and Safety of Sevuparin, a Novel Non-Anti-Coagulant Heparinoid, in Patients with Acute Painful Vaso-Occlusive Crisis; A Global, Multicenter Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial (TVOC01)

Blood, 2019-11, Vol.134 (Supplement_1), p.614-614

2019

Volltextzugriff (PDF)

Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet. Haematology, 2021-05, Vol.8 (5), p.e334-e343

2021

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled crossover study of [α.sub.4][β.sub.2.sup.] nicotinic acetylcholine receptor agonist AZD1446 in adults with attention-deficit/hyperactivity disorder

Psychopharmacology, 2014-03, Vol.231 (6), p.1251

2014

Volltextzugriff (PDF)

Do leukotrienes reduce apoptosis?

Prostaglandins & other lipid mediators, 1999-12, Vol.59 (1), p.32-32

1999

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieGastroenterology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis: A Randomized Controlled Trial

A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells

S283: THE NON‐ANTICOAGULANT HEPARINOID COMPOUND, SEVUPARIN, STRONGLY REDUCES HEPCIDIN EXPRESSION IN CELLS, IN MICE AND IN HEALTHY VOLUNTEERS

The Inflammatory Mediator Leukotriene D4 Induces β-Catenin Signaling and Its Association with Antiapoptotic Bcl-2 in Intestinal Epithelial Cells

A phase II study of epirubicin, cisplatin and capecitabine as neoadjuvant chemotherapy in locally advanced or inflammatory breast cancer

Regulation of leukotriene-dependent induction of cyclooxygenase-2 and Bcl-2

The Heparinoid Sevuparin Improves Anemia and Kidney Status in a Mouse Model of Chronic Kidney Disease

The leukotriene receptor CysLT1 and 5-lipoxygenase are upregulated in colon cancer

Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study

A phase 1/2 study with birinapant in combination with pembrolizumab

A randomized, double-blind, placebo-controlled crossover study of α4β2 nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder

Population pharmacokinetics and safety of AZD1446, a neuronal nicotinic receptor agonist, administered in healthy volunteers

Massive Fundic Gland Polyposis in a Patient Receiving Protracted Proton-Pump Inhibitor Medication

Abstract 5101: Defining exposure-PD and efficacy relationships with the novel liver-targeting nucleotide prodrug MIV-818 for the treatment of liver cancers

A randomized, double-blind, placebo-controlled crossover study of [alpha]^sub 4^[beta]^sub 2^ nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder

Do leukotrienes increase cell viability in human intestinal epithelial cells?

Human papillomavirus, viral load and proliferation rate in recurrent respiratory papillomatosis in response to alpha interferon treatment

Pro-inflammatory mediator leukotriene D4 induces transcriptional activity of potentially oncogenic genes

Inflammatory Mediator Leukotriene D₄ Induces [beta]-Catenin Signaling and Its Association with Antiapoptotic Bcl-2 in Intestinal Epithelial Cells

The inflammatory mediator leukotriene D4 induces beta -catenin signaling and its association with anti-apoptotic Bcl-2 in intestinal epithelial cells

A randomized, double-blind, placebo-controlled crossover study of α4β 2 nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder

Efficacy and Safety of Sevuparin, a Novel Non-Anti-Coagulant Heparinoid, in Patients with Acute Painful Vaso-Occlusive Crisis; A Global, Multicenter Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial (TVOC01)

Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

A randomized, double-blind, placebo-controlled crossover study of [α.sub.4][β.sub.2.sup.] nicotinic acetylcholine receptor agonist AZD1446 in adults with attention-deficit/hyperactivity disorder

Do leukotrienes reduce apoptosis?

Aktive Filter

Suchergebnisse filtern